NDC 78206-187 – Hadlima
Adalimumab 40 mg/.4mL · Solution · Subcutaneous
Product NDC78206-187
Product details
- Brand name
- Hadlima
- Generic name
- adalimumab-bwwd
- Labeler
- Organon LLC
- Dosage form
- Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761059
- Marketed since
- July 1, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Adalimumab 40 mg/.4mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 78206-187-01 | 2 SYRINGE in 1 CARTON (78206-187-01) / .4 mL in 1 SYRINGE (78206-187-99) | Jul 1, 2023 |
| 78206-187-59 sample | 2 SYRINGE in 1 CARTON (78206-187-59) / .4 mL in 1 SYRINGE (78206-187-58) | Jul 1, 2023 |
Other Hadlima products
- 50090-6705 Adalimumab 40 mg/.8mL · Solution · A-S Medication Solutions
- 50090-6706 Adalimumab 40 mg/.8mL · Solution · A-S Medication Solutions
- 50090-6707 Adalimumab 40 mg/.4mL · Solution · A-S Medication Solutions
- 78206-183 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-184 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-185 Adalimumab 40 mg/.8mL · Solution · Organon LLC
- 78206-186 Adalimumab 40 mg/.4mL · Solution · Organon LLC